CIK 0001501989
- Accelerated filer
CytomX Therapeutics, Inc.
Sign in to watch- Ticker
- CTMX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 273521219
- Phone
- +1 650-515-3185
- Business address
- 151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-06-20 | Exter Neil Director | Grant or award · Stock Option (right to buy) | +14,000 | 14,000 | ||
| 2017-03-27 | Exter Neil Director | Sale | −0 | 0 | ||
| 2017-03-23 | Exter Neil Director | Sale | −0 | 0 | ||
| 2016-11-07 | Exter Neil Director | Other disposition | −0 | 0 | ||
| 2016-06-10 | Exter Neil Director | Grant or award · Stock Option (right to buy) | +14,000 | 14,000 |
Page 1 of 1 · 5 trades